You are here
Which clinical trial scheme should I choose?
This tool helps Australian trial sponsors determine whether the CTN or the CTA scheme is most appropriate for their clinical trial.
Other pathways are available to access 'unapproved' therapeutic goods for individual patients. Please note that health professionals should not use these pathways for the purposes of conducting a clinical trial.
See our guidance on Accessing unapproved products for more information about gaining access to 'unapproved' products.